Lancet Series on the commercial determinants of health1 highlighted how commercial organisations shape health policies, both ...

Over the past decades, bronchiectasis has been neglected, despite the global burden.1,2 To date, better diagnosis due to easy ...

Population-based analyses of new vaccination programmes provide robust real-world evidence for post-licensure vaccine ...

On March 13, 2025, the UK Government announced that it was disbanding NHS England, the arm's length government body ...

There is a growing opportunity to expand clinical research capacity in Africa, and numerous organisations are contributing to this effort. To name a few: the African Medicines Agency provides ...

Vaccination remains the most cost-effective public health intervention, preventing millions of deaths and reducing disease burden worldwide.1 However, their impact is rendered meaningless if vaccines ...

Asthma and atopic dermatitis are chronic inflammatory diseases of the airways and the skin, respectively, which affect hundreds of millions of children and adults globally. Most patients with asthma ...

In 2023, commitments made at the UN High-Level Meeting on the Fight Against Tuberculosis offered a renewed sense of hope and purpose after the COVID-19 pandemic.1 Nevertheless, tuberculosis disease ...

The US Agency for International Development (USAID) is no more. Marco Rubio, the US Secretary of State, has announced that 83 ...

I think what I've really wanted to do since I was a teenager was work on HIV and TB, and conditions that affected people who ...

WHO issued a statement outlining the grave consequences of the US decision to drastically cut international funding for tuberculosis. WHO noted that countries with high burdens of tuberculosis disease ...

During medical school, I came across a professor who introduced me to research—up until that point, I was content with being ...